RIPE-KG · Version 1.1.0 · Resource

ripekg:work/10.3324%2Fhaematol.2021.279232

https://w3id.org/ripe/ripe-kg/work/10.3324%2Fhaematol.2021.279232
SubjectPredicateObject
ripekg:work/10.1136%2Fbmj-2025-084314Anti-CD38 monoclonal antibody CM313 for primary immune thrombocytopenia: multicentre, randomised, placebo controlled, phase 2 trial http://purl.org/spar/cito/cites ripekg:work/10.3324%2Fhaematol.2021.279232Daratumumab, an original approach for treating multi-refractory autoimmune cytopenia
ripekg:work/10.3324%2Fhaematol.2021.279232Daratumumab, an original approach for treating multi-refractory autoimmune cytopenia prism:doi 10.3324/haematol.2021.279232
ripekg:work/10.3324%2Fhaematol.2021.279232Daratumumab, an original approach for treating multi-refractory autoimmune cytopenia dcterms:title Daratumumab, an original approach for treating multi-refractory autoimmune cytopenia
ripekg:work/10.3324%2Fhaematol.2021.279232Daratumumab, an original approach for treating multi-refractory autoimmune cytopenia rdf:type node1
ripekg:work/10.3324%2Fhaematol.2021.279232Daratumumab, an original approach for treating multi-refractory autoimmune cytopenia rdf:type http://purl.org/spar/fabio/Work
ripekg:work/10.3324%2Fhaematol.2021.279232Daratumumab, an original approach for treating multi-refractory autoimmune cytopenia rdf:type rdfs:Resource
ripekg:work/10.3324%2Fhaematol.2021.279232Daratumumab, an original approach for treating multi-refractory autoimmune cytopenia rdf:type owl:Thing
ripekg:work/10.3324%2Fhaematol.2021.279232Daratumumab, an original approach for treating multi-refractory autoimmune cytopenia rdf:type prov:Entity
ripekg:work/10.3324%2Fhaematol.2021.279232Daratumumab, an original approach for treating multi-refractory autoimmune cytopenia rdf:type ripe:WorkWork
ripekg:work/10.3324%2Fhaematol.2021.279232Daratumumab, an original approach for treating multi-refractory autoimmune cytopenia owl:sameAs https://semopenalex.org/work/W3187155906